ArticleBriefings in bioinformatics2025
On the impact of local protein structure features on prediction of major histocompatibility complex class I and II antigen presentation.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- QSyncFold: quantum neural network for multidimensional sync-discovery in protein folding.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Antigen presentation by major histocompatibility complex (MHC) molecules is a complex pathway essential for T cell-mediated immunity. The pathway involves unfolding and processing of the antigen protein structure, yet limited work has been made evaluating the potential influence of local protein structure on the prediction of antigen processing and presentation. Here, we investigated this by integrating local structural features-disorder score, relative surface accessibility, and the probabilities of α-helix, β-sheet, and coil-into an NNAlign-based framework for predicting MHC class I and HLA-DR antigen presentation. Large-scale eluted ligand datasets were used to train and validate our models, demonstrating that for MHC class I, the addition of structural features yielded marginal, nonsignificant improvements in performance. In contrast, for HLA-DR ligands, models incorporating positional structural information showed a significant yet limited performance boost. Post-hoc analysis revealed no clear amino acid enrichment patterns associated with structural propensities. Rather the HLA-specific gain in performance was found to be linked to the number of positive instances seen in training. Stratification by cellular localisation indicated that peptides from endolysosomal proteins benefited more from structural integration than those from cytosolic sources. Our comprehensive benchmark shows that incorporating local protein structural features improves epitope prediction for MHC class II ligands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.